Priveterra Acquisition Corp. [Rocket]

Overview

Priveterra Acquisition Corp.

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
10/02/2023	8-K	Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
08/22/2023	SC 13D/A	Strathspey Crown Holdings, LLC reports a 5.5% stake in AEON Biopharma, Inc.
08/22/2023	DEL AM	Form DEL AM - Delaying amendment:
08/18/2023	S-1	Form S-1 - General form for registration of securities under the Securities Act of 1933:
08/16/2023	4	Thunen Shelley B (Director) has filed a Form 4 on AEON Biopharma, Inc.
08/16/2023	4	PALMISANO ROBERT J (10% Owner) has filed a Form 4 on AEON Biopharma, Inc.
08/16/2023	4	FISCHER JOST (Director) has filed a Form 4 on AEON Biopharma, Inc.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21
Revenues	0.0	0.0
Cost of goods sold	3.3	1.9
Gross profit	-3.3	-1.9
Selling, general and administrative	0.0	0.0
EBIT	-3.3	-1.9
Pre-tax income	7.3	8.2
Income taxes	0.9	0.0
Tax rate	12.2%	0.0%
Net income	6.4	8.2

Diluted EPS	$0.10	$0.15
Shares outstanding (diluted)	62.1	55.8

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy